Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05669911 · ClinicalTrials.gov registry record · NA
Development of a Self-collection Device for Cervical Cancer Screening
A NA study of Human Papilloma Virus and Human Papilloma Virus Infection Type 16, sponsored by Teal Health.
- Active
- Registry status
- NA
- Development phase
- 235
- Enrollment target
- 6
- Study locations
NCT05669911 is a NA study of Human Papilloma Virus and Human Papilloma Virus Infection Type 16 that is active but no longer recruiting, run by Teal Health. The registered enrollment target is 235 participants, below the 615-participant average among 26 other Human Papilloma Virus trials with a reported enrollment target (62% lower). The trial reports 6 study locations across 6 states.
The verdict
NCT05669911, a NA study of Human Papilloma Virus and Human Papilloma Virus Infection Type 16, is active but no longer recruiting, sponsored by Teal Health.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 235 participants
- Enrollment target
- 6
- Study locations
Study Summary
Evaluation of a novel self-collection device for cervical cancer screening.
Conditions Studied
Interventions
- DEVICE Teal Health Self-Collection Device Group
Study Locations (6)
California
- Crescendo MD - Portola Valley
Colorado
- University of Colorado Anschutz Medical Campus - Aurora
Louisiana
- Woman's Hospital - Baton Rouge
Massachusetts
- Boston Metro - Westwood
Texas
- Planned Parenthood Gulf Coast - Houston
Wisconsin
- University of Wisconsin - Madison - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 235 participants |
| Start Date | 2022-08-28 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05669911
The ClinicalTrials.gov registry entry for NCT05669911 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 235 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 615-participant average among 26 other Human Papilloma Virus trials with a reported enrollment target (62% lower). The listed sponsor is Teal Health, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Human Papilloma Virus appearing as the primary indexed condition, and to 1 intervention - of which Teal Health Self-Collection Device Group is the first listed.
NCT05669911 reports 6 study locations spanning 6 distinct geographic areas - top geographies include California, Colorado, Louisiana.
Frequently Asked Questions
What is clinical trial NCT05669911 about?
NCT05669911 is a clinical study titled "Development of a Self-collection Device for Cervical Cancer Screening". Evaluation of a novel self-collection device for cervical cancer screening.
What is the current status of trial NCT05669911?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 235 participants. The study started on 2022-08-28. Estimated completion is 2023-12-31.
What conditions does trial NCT05669911 study?
This clinical trial studies the following conditions: Human Papilloma Virus, Human Papilloma Virus Infection Type 16, Human Papilloma Virus Infection Type 18.
What interventions are being tested in trial NCT05669911?
The interventions under investigation include: Teal Health Self-Collection Device Group (DEVICE).
Who is sponsoring clinical trial NCT05669911?
This trial is sponsored by Teal Health, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05669911 being conducted?
This trial has 6 study locations across California, Colorado, Louisiana, Massachusetts, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Human Papilloma Virus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine
RECRUITING · NA
-
PopSci CHW4CervixHealth
RECRUITING · NA
-
Advancing HPV Vaccination Among HIV Positive Adults: The CHAMPS Study
RECRUITING · NA
-
Impact of Standing Orders Optimization
ACTIVE NOT RECRUITING · NA
-
Impact of Financial Incentives
ACTIVE NOT RECRUITING · NA
-
TORS De-Intensification Protocol Version 2.0: Dose and Volume Reduction in the Neck
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Human Papilloma Virus
All registered trials for this condition
Human Papilloma Virus Infection Type 16
All registered trials for this condition
California
All trials with a study site in California
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.